{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 464387196
| IUPAC_name = 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
| image = Sarafloxacin.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|sarafloxacin}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 98105-99-8
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| PubChem = 56208
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 50727
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = RC3WJ907XY
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 37858

<!--Chemical data-->
| chemical_formula =  
| C=20 | H=17 | F=2 | N=3 | O=3 
| molecular_weight = 385.36 g/mol
| smiles = Fc1ccc(cc1)N\3c2cc(c(F)cc2C(=O)C(/C(=O)O)=C/3)N4CCNCC4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H17F2N3O3/c21-12-1-3-13(4-2-12)25-11-15(20(27)28)19(26)14-9-16(22)18(10-17(14)25)24-7-5-23-6-8-24/h1-4,9-11,23H,5-8H2,(H,27,28)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XBHBWNFJWIASRO-UHFFFAOYSA-N
}}

'''Sarafloxacin''' ([[International Nonproprietary Name|INN]]) is a [[Quinolone antibiotic|quinolone]] [[antibiotic]] drug,<ref>{{Cite journal  | title = Evaluation of certain veterinary drug residues in food. Fiftieth report of the joint FAO/WHO Expert Committee on Food Additives. | journal = World Health Organ Tech Rep Ser | volume = 888 | issue =  | pages = i-vii, 1–95 | month =  | year = 1999 | doi =  | PMID = 10416362 }}</ref><ref>{{Cite journal  | last1 = Gingerich | first1 = WH. | last2 = Stehly | first2 = GR. | last3 = Clark | first3 = KJ. | last4 = Hayton | first4 = WL. | title = Crop grouping: a proposal for public aquaculture. | journal = Vet Hum Toxicol | volume = 40 Suppl 2 | issue =  | pages = 24–31 | month =  | year = 1998 | doi =  | PMID = 9823579 }}</ref> which was removed from clinical use by its manufacturer [[Abbott Laboratories]] from April 30, 2001.

==See also==
*[[Quinolone antibiotic|Quinolone]]
*[[Adverse effects of fluoroquinolones]]

==References==
{{reflist}}

{{antibiotic-stub}}

{{QuinoloneAntiBiotics}}

[[Category:Fluoroquinolone antibiotics]]
[[Category:Fluoroarenes]]
[[Category:Piperazines]]
[[Category:Carboxylic acids]]